Reducing the risk for stroke in patients with myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy.
Gotto
Antonio M
AM
Farmer
John A
JA
D002784:Cholesterol / Q000097:blood*; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D015994:Incidence; D008297:Male; D015201:Meta-Analysis as Topic; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000453:epidemiology* / Q000628:therapy; D017202:Myocardial Ischemia / Q000453:epidemiology / Q000517:prevention & control*; D017035:Pravastatin / Q000627:therapeutic use; D011446:Prospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D012537:Scandinavian and Nordic Countries / Q000453:epidemiology; D020521:Stroke / Q000453:epidemiology* / Q000517:prevention & control*; D015996:Survival Rate; D013995:Time; D014481:United States / Q000453:epidemiology
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002784:Cholesterol; D017035:Pravastatin